Stay updated on ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial
Sign up to get notified when there's something new on the ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial page.

Latest updates to the ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedLocations were reorganized under a single 'Locations' header with state subsections for Arizona, California, Florida, Nevada, Texas, and Utah, replacing the prior separate 'Arizona Locations', 'California Locations', etc. This clarifies where the study is recruiting and makes site information easier for potential participants to use.SummaryDifference0.7%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe Publications section now notes that items are automatically filled from PubMed and may not all pertain to the study, and the revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check45 days agoChange DetectedThe funding-status banner was removed from the page, removing the notice about government funding lapses and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedThe new screenshot shows a redesigned header and updated navigation on the Indiana General Assembly page, with the main content sections and notices unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedMajor update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference5%

- Check95 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.SummaryDifference0.6%

Stay in the know with updates to ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial page.